Ointment

DRUG2 trials

Sponsors

Serentis Ltd., University of Zurich

Conditions

Atopic DermatitisRecurrent Herpes Labialis

Phase 2

Safety and Efficacy of SRD441 Ointment in Patients With Atopic Dermatitis

CompletedNCT00882245

Serentis Ltd.Atopic Dermatitis

Start: 2009-04-30End: 2009-10-31Updated: 2009-10-30

Place Controlled Study to Treat Recurrent Herpes Labialis.

CompletedNCT00914745

University of ZurichRecurrent Herpes Labialis

Start: 2009-04-30End: 2011-05-31Updated: 2011-08-08

Related Papers

The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study.

2010-09-0713 citations